Epithelial-mesenchymal transition can suppress major attributes of human epithelial tumor-initiating cells.
about
Protein kinase C α is a central signaling node and therapeutic target for breast cancer stem cellsNew Insights into the Crossroads between EMT and Stemness in the Context of CancerWhen Prostate Cancer Circulates in the BloodstreamDifferentiation and transdifferentiation potentials of cancer stem cellsEpithelial to Mesenchymal Transition in a Clinical PerspectiveReactivating p53 functions by suppressing its novel inhibitor iASPP: a potential therapeutic opportunity in p53 wild-type tumorsThe role of EMT and MET in cancer disseminationAndrogen receptor and prostate cancer stem cells: biological mechanisms and clinical implicationsImplications of the Hybrid Epithelial/Mesenchymal Phenotype in MetastasisEpithelial-mesenchymal plasticity of breast cancer stem cells: implications for metastasis and therapeutic resistanceRegulation of ovarian cancer stem cells or tumor-initiating cellsEpithelial-mesenchymal plasticity in carcinoma metastasisEpithelial homeostasisIntratumoral heterogeneity: Clonal cooperation in epithelial-to-mesenchymal transition and metastasismiR-100 induces epithelial-mesenchymal transition but suppresses tumorigenesis, migration and invasionReal-time motion analysis reveals cell directionality as an indicator of breast cancer progressionDistinctive properties of metastasis-initiating cellsTumor cell dormancyCellular Plasticity in Prostate Cancer Bone MetastasisSystems biology of cancer: entropy, disorder, and selection-driven evolution to independence, invasion and "swarm intelligence"An epigenetically distinct breast cancer cell subpopulation promotes collective invasionTumour-initiating capacity is independent of epithelial-mesenchymal transition status in breast cancer cell lines.Targeting Colorectal Cancer Proliferation, Stemness and Metastatic Potential Using Brassicaceae Extracts Enriched in Isothiocyanates: A 3D Cell Model-Based Study.Characteristics of circulating tumor cells in organ metastases, prognosis, and T lymphocyte mediated immune response.New insights into the role of ID proteins in breast cancer metastasis: a MET affairBrain metastasis-initiating cells: survival of the fittest.Harnessing protein kinase A activation to induce mesenchymal-epithelial programs to eliminate chemoresistant, tumor-initiating breast cancer cellsEpithelial/mesenchymal plasticity: how have quantitative mathematical models helped improve our understanding?Revisiting epithelial-mesenchymal transition in cancer metastasis: the connection between epithelial plasticity and stemness.EMT and MET: necessary or permissive for metastasis?Snail1-dependent control of embryonic stem cell pluripotency and lineage commitmentMultilayer control of the EMT master regulators.SPARC mediates metastatic cooperation between CSC and non-CSC prostate cancer cell subpopulations.Hypoxia induces EMT in low and highly aggressive pancreatic tumor cells but only cells with cancer stem cell characteristics acquire pronounced migratory potential.Isolation and characterization of tumor cells from the ascites of ovarian cancer patients: molecular phenotype of chemoresistant ovarian tumors.The role of epithelial plasticity in prostate cancer dissemination and treatment resistanceThe mannose receptor LY75 (DEC205/CD205) modulates cellular phenotype and metastatic potential of ovarian cancer cells.Tackling the cancer stem cells - what challenges do they pose?Grhl2 determines the epithelial phenotype of breast cancers and promotes tumor progression.Targeting metastasis-initiating cells through the fatty acid receptor CD36.
P2860
Q24329077-4F274148-562C-4923-834D-55B6BF0FB75BQ26764831-BDADD5A9-2359-4243-9713-F866B8B53C9CQ26768470-CB4ECF6D-E6DA-4FD6-9593-56296A582D4BQ26782242-9689E0A4-3FBF-4C27-AF88-A0157332AC68Q26783554-69F1F087-DDE4-4223-9052-9D34603248E9Q26783710-9E6A65F6-ED81-47FE-8AC7-B67BE61C0C9FQ26796298-ED1AEACA-17C7-48F4-9AA7-94BD0FCBCC1CQ26797063-B4AB410D-7BEF-41DF-A308-C02BCF9B4CB4Q26799987-F6D89937-CBF3-47F5-9227-B667DD6B0D68Q26824386-7781ABDF-4D38-4606-9B1A-4E5D1BD10C69Q26853096-91F0D014-F9F6-444D-BEBE-1F2E1104727FQ26859804-CA3B5158-510B-498C-8863-9D0E6E55FB98Q26864115-FC7F1380-9EBD-48F3-BAC9-0B15606279E4Q26991480-A030E848-6E9E-4D82-B341-941392272DE9Q27316744-4EE8B8D6-9FBE-43F8-A845-79AAA4403A69Q27334635-7C829C68-BC24-49F5-BCD8-6DEA7CC82DEBQ28069801-AAA34F13-2E74-44CC-A3E2-05ABD5EE27C3Q28073065-F1628A6B-F214-4ECA-BBE3-B9561B10BA5AQ28085013-A84DD01B-C105-468F-A819-E67D4B3673FFQ28391909-0F8994BE-150E-4734-BEDD-5C0B53AF068DQ30654061-32565184-3079-4904-888D-1EF9125164B7Q33613560-629920EA-B1D9-4C5B-AA6B-154E24FB578CQ33616786-19C81B33-C4EC-4D55-BD7B-600C0BDA0DF2Q33650301-0BC69D33-798B-4A10-9FB0-3B7E5C390062Q33739743-EF188132-8719-41A3-90FB-FCAFC0DD90E2Q33755959-DDDE4F97-914C-4DC4-ADC3-E7994D42D949Q33865464-AEB55E3D-8460-4A1D-A40F-93BDCF0B0C81Q33869760-C39BAB44-67DD-44D0-A9EC-9735FCCA528EQ33869770-088335FD-3B79-4A24-ACBD-5EC1BA0BC407Q33869775-19F356BC-694F-4D5C-A431-384F29CEDD63Q33972770-0AE53A4F-B5A6-4098-9C8E-3E93C1279CA1Q34340552-4F801316-28FE-4F9B-9635-47BEB285A025Q34410598-12FAE9D8-5ADF-4715-844D-206F36671157Q34438815-FB2C7F60-A7B6-4EB8-B642-CC6E9067FAD8Q34442318-A264B5AE-0876-4C94-9662-D2C7218550C7Q34505037-4E6F099A-3198-467C-AE8B-1294909D3066Q34513833-70F7E32A-3B03-42D1-B800-89265F865113Q34523263-9835413E-C241-4B9F-A683-2143871411F7Q34531593-B22922D3-0EA0-4F55-AE28-0D7958BCAF84Q34547374-D8A2C931-52E8-46BF-9A87-BF783F93D363
P2860
Epithelial-mesenchymal transition can suppress major attributes of human epithelial tumor-initiating cells.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Epithelial-mesenchymal transit ...... helial tumor-initiating cells.
@ast
Epithelial-mesenchymal transit ...... helial tumor-initiating cells.
@en
type
label
Epithelial-mesenchymal transit ...... helial tumor-initiating cells.
@ast
Epithelial-mesenchymal transit ...... helial tumor-initiating cells.
@en
prefLabel
Epithelial-mesenchymal transit ...... helial tumor-initiating cells.
@ast
Epithelial-mesenchymal transit ...... helial tumor-initiating cells.
@en
P2093
P2860
P50
P356
P1476
Epithelial-mesenchymal transit ...... helial tumor-initiating cells.
@en
P2093
Alexia Martínez de Paz
Anna Arnal-Estapé
Antonio García de Herreros
Brian J Ell
Catalina Ulloa
Conchi Estarás
Daniel Álvarez-Simón
Jordi Milà
Juan José Lozano
P2860
P304
P356
10.1172/JCI59218
P407
P50
P577
2012-04-16T00:00:00Z